Moye White partner Garrett Graff recently spoke with Natural Products Insider reporter Josh Long about why marketers of delta-8 THC should be more worried about state legislatures and regulatory agencies than the FDA, despite its recent warnings.
FDA’s recent batch of warning letters to marketers of delta-8 THC is unlikely to cool the sale of these products in the U.S., some legal experts said, citing the agency’s lack of follow-up enforcement actions in cases involving CBD and other ingredients.
In the article, Graff is quoted as saying, “I largely suspect there will be little chilling effect, if any, toward the sale of delta-8 products. FDA’s rhetoric in writing but lack of actual enforcement activity does not particularly threaten or cause fear for those in the hemp industry.”
The interview was featured in an article, Lawyers Skeptical FDA Warning Letters Will Chill delta-8 THC Market, that published on May 16.
Read the full article in Natural Products Insider.
About Moye White LLP
Moye White LLP is a business law firm serving clients throughout the United States and internationally, with offices in Colorado and Georgia. The firm provides legal representation across a wide variety of transactional and litigation matters, offering strategic, business-oriented counsel to public, private, and governmental clients in complex business and real estate transactions and disputes. As one of the earliest national law firms to achieve B Corp certification, Moye White meets rigorous standards of social and environmental performance, transparency, and accountability. For more information, please visit moyewhite.com or contact Managing Partner Thomas List at 303-292-2900 or email@example.com.